Drugs / MRCP001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03522467 | Jul 2018 → Jun 2020 | cancer, chronic pain syndrome | Aurora Cannabis Inc | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MRCP001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03522467 ↗ |
| Route | Oral | “orally administered cannabis oil formulation” NCT03522467 ↗ |